low blood volume LC‐MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children

Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metaboli...

Full description

Saved in:
Bibliographic Details
Published inJournal of separation science Vol. 34; no. 24; pp. 3568 - 3577
Main Authors Clavijo, Claudia F, Thomas, James Joseph, Cromie, Meghan, Schniedewind, Björn, Hoffman, Keith L, Christians, Uwe, Galinkin, Jeffrey L
Format Journal Article
LanguageEnglish
Published Weinheim WILEY‐VCH Verlag 01.12.2011
WILEY-VCH Verlag
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC‐MS/MS method based on minimally invasive, low blood volume sampling. LC‐MS/MS was used for the simultaneous analysis of fentanyl, despropionyl fentanyl (DPF), and norfentanyl from dried blood samples (DBS) collected on filter paper. Positive ions were monitored using multiple reaction monitoring. Since the standard matrix for measuring fentanyl blood concentrations is plasma, the assay was developed and validated in plasma, whole blood, and then DBS. Our method was able to measure clinically relevant levels of fentanyl and its metabolites. In DBS, the lower limits of quantification were 100 pg/mL for fentanyl with a range of reliable response from 0.1 to 100 ng/mL (r2>0.99) and 250 pg/mL for both DPF and norfentanyl with a range of reliable response from 0.25 to 100 ng/mL (r2>0.99). In plasma and in DBS inter‐day accuracy and precisions of fentanyl met predefined acceptance criteria and also indicated comparable assay performance in both matrices.
AbstractList Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC‐MS/MS method based on minimally invasive, low blood volume sampling. LC‐MS/MS was used for the simultaneous analysis of fentanyl, despropionyl fentanyl (DPF), and norfentanyl from dried blood samples (DBS) collected on filter paper. Positive ions were monitored using multiple reaction monitoring. Since the standard matrix for measuring fentanyl blood concentrations is plasma, the assay was developed and validated in plasma, whole blood, and then DBS. Our method was able to measure clinically relevant levels of fentanyl and its metabolites. In DBS, the lower limits of quantification were 100 pg/mL for fentanyl with a range of reliable response from 0.1 to 100 ng/mL (r2>0.99) and 250 pg/mL for both DPF and norfentanyl with a range of reliable response from 0.25 to 100 ng/mL (r2>0.99). In plasma and in DBS inter‐day accuracy and precisions of fentanyl met predefined acceptance criteria and also indicated comparable assay performance in both matrices.
Abstract Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC‐MS/MS method based on minimally invasive, low blood volume sampling. LC‐MS/MS was used for the simultaneous analysis of fentanyl, despropionyl fentanyl (DPF), and norfentanyl from dried blood samples (DBS) collected on filter paper. Positive ions were monitored using multiple reaction monitoring. Since the standard matrix for measuring fentanyl blood concentrations is plasma, the assay was developed and validated in plasma, whole blood, and then DBS. Our method was able to measure clinically relevant levels of fentanyl and its metabolites. In DBS, the lower limits of quantification were 100 pg/mL for fentanyl with a range of reliable response from 0.1 to 100 ng/mL ( r 2 >0.99) and 250 pg/mL for both DPF and norfentanyl with a range of reliable response from 0.25 to 100 ng/mL ( r 2 >0.99). In plasma and in DBS inter‐day accuracy and precisions of fentanyl met predefined acceptance criteria and also indicated comparable assay performance in both matrices.
Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC-MS/MS method based on minimally invasive, low blood volume sampling. LC-MS/MS was used for the simultaneous analysis of fentanyl, despropionyl fentanyl (DPF), and norfentanyl from dried blood samples (DBS) collected on filter paper. Positive ions were monitored using multiple reaction monitoring. Since the standard matrix for measuring fentanyl blood concentrations is plasma, the assay was developed and validated in plasma, whole blood, and then DBS. Our method was able to measure clinically relevant levels of fentanyl and its metabolites. In DBS, the lower limits of quantification were 100 pg/mL for fentanyl with a range of reliable response from 0.1 to 100 ng/mL (r(2)>0.99) and 250 pg/mL for both DPF and norfentanyl with a range of reliable response from 0.25 to 100 ng/mL (r(2)>0.99). In plasma and in DBS inter-day accuracy and precisions of fentanyl met predefined acceptance criteria and also indicated comparable assay performance in both matrices.
Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC-MS/MS method based on minimally invasive, low blood volume sampling. LC-MS/MS was used for the simultaneous analysis of fentanyl, despropionyl fentanyl (DPF), and norfentanyl from dried blood samples (DBS) collected on filter paper. Positive ions were monitored using multiple reaction monitoring. Since the standard matrix for measuring fentanyl blood concentrations is plasma, the assay was developed and validated in plasma, whole blood, and then DBS. Our method was able to measure clinically relevant levels of fentanyl and its metabolites. In DBS, the lower limits of quantification were 100pg/mL for fentanyl with a range of reliable response from 0.1 to 100ng/mL (r(2)>0.99) and 250pg/mL for both DPF and norfentanyl with a range of reliable response from 0.25 to 100ng/mL (r(2)>0.99). In plasma and in DBS inter-day accuracy and precisions of fentanyl met predefined acceptance criteria and also indicated comparable assay performance in both matrices.
Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most commonly used drug for these procedures, and its metabolites is still incomplete. To facilitate pharmacokinetic studies of fentanyl and its metabolites in neonates and other children, we developed and validated an LC-MS/MS method based on minimally invasive, low blood volume sampling. LC-MS/MS was used for the simultaneous analysis of fentanyl, despropionyl fentanyl (DPF), and norfentanyl from dried blood samples (DBS) collected on filter paper. Positive ions were monitored using multiple reaction monitoring. Since the standard matrix for measuring fentanyl blood concentrations is plasma, the assay was developed and validated in plasma, whole blood, and then DBS. Our method was able to measure clinically relevant levels of fentanyl and its metabolites. In DBS, the lower limits of quantification were 100pg/mL for fentanyl with a range of reliable response from 0.1 to 100ng/mL (r2>0.99) and 250pg/mL for both DPF and norfentanyl with a range of reliable response from 0.25 to 100ng/mL (r2>0.99). In plasma and in DBS inter-day accuracy and precisions of fentanyl met predefined acceptance criteria and also indicated comparable assay performance in both matrices. [PUBLICATION ABSTRACT]
Author Schniedewind, Björn
Clavijo, Claudia F.
Galinkin, Jeffrey L.
Cromie, Meghan
Thomas, James Joseph
Hoffman, Keith L.
Christians, Uwe
Author_xml – sequence: 1
  fullname: Clavijo, Claudia F
– sequence: 2
  fullname: Thomas, James Joseph
– sequence: 3
  fullname: Cromie, Meghan
– sequence: 4
  fullname: Schniedewind, Björn
– sequence: 5
  fullname: Hoffman, Keith L
– sequence: 6
  fullname: Christians, Uwe
– sequence: 7
  fullname: Galinkin, Jeffrey L
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21916010$$D View this record in MEDLINE/PubMed
BookMark eNqFkc1u1DAYRSNURH9gyxIssekm08-OE8dLFEEBTUEoVO3OchKbekjsqZ3Qzo5H6DPyJLhKiYANK_-de_RZ9zDZs86qJHmOYYUByMkmhHZFAMcDJeRRcoALnKc8w3Rv2UOxnxyGsAHArOTwJNknmOMCMBwkd727QU3vXIe-u34aFFpXP3_cndUnZzWSIcgd0s6j8Uqh60na0WjTytE4i5xGWtlR2l2PpO2QGQMa5CbCgxpl43ozqoCs839RnQpb77ZREC-WF2NRe2X6ziv7NHmsZR_Us4f1KDl_--ZL9S5dfzp9X71ep20OmKSaU8Y4UNxq4JI3RcZ0mZMOypYVRVlQpVjDSKE1pTkwrkGqDqjEGmjBMpwdJcezN45zPakwisGEVvW9tMpNQWAgpKSEEx7RV_-gGzd5G6cTOKc5hgx4FqnVTLXeheCVFltvBul3USXuuxL3XYmlqxh48aCdmkF1C_67nAjwGbgxvdr9Ryc-1HX1pzydsyaM6nbJSv9NxO-zXFx8PBWfLy8v1rTCgkX-5cxr6YT86k0Q53XUUQDggDOe_QI9krwp
CitedBy_id crossref_primary_10_1016_j_jchromb_2017_09_030
crossref_primary_10_1016_j_jpeds_2015_08_032
crossref_primary_10_1097_FTD_0000000000000674
crossref_primary_10_1016_j_forc_2019_100180
crossref_primary_10_4155_bio_2017_0174
crossref_primary_10_1111_1556_4029_15282
crossref_primary_10_2116_analsci_18R004
crossref_primary_10_3109_10408444_2011_650790
crossref_primary_10_1039_C7AY00532F
crossref_primary_10_1097_FTD_0b013e31828e7e6b
crossref_primary_10_1002_jssc_201200378
crossref_primary_10_1002_mas_21441
crossref_primary_10_1016_j_jchromb_2019_05_025
crossref_primary_10_1039_D2AN00946C
crossref_primary_10_1213_ANE_0000000000006808
crossref_primary_10_1016_j_forc_2023_100526
crossref_primary_10_1111_jvp_12501
crossref_primary_10_1111_ajt_15199
crossref_primary_10_1213_ANE_0000000000001088
crossref_primary_10_1002_jssc_201400152
crossref_primary_10_4155_bio_14_156
crossref_primary_10_1213_ANE_0000000000006554
crossref_primary_10_1007_s00414_014_1040_y
crossref_primary_10_1002_dta_1927
crossref_primary_10_1208_s12249_018_1103_3
crossref_primary_10_1016_j_clinbiochem_2016_05_004
crossref_primary_10_1002_bmc_4290
crossref_primary_10_1039_D0TB01509A
crossref_primary_10_1111_ajt_13935
crossref_primary_10_1016_j_jchromb_2012_07_005
crossref_primary_10_1002_jssc_202000168
crossref_primary_10_1093_jat_bky096
crossref_primary_10_1038_s41598_020_68348_w
crossref_primary_10_1111_1556_4029_12953
crossref_primary_10_1007_s12024_021_00434_5
Cites_doi 10.1016/j.jpba.2004.09.024
10.1016/S1570-0232(02)00142-3
10.1016/j.aca.2003.12.007
10.1006/mchj.1996.0017
10.1007/s00216-011-4775-z
10.1097/01.ogx.0000248747.52343.5f
10.1016/S0003-2670(03)00574-9
10.1016/j.aca.2008.07.047
10.1016/S0095-5108(02)00017-9
10.1016/S0003-2670(02)00133-2
10.1016/j.jpba.2006.12.016
10.1016/S0378-4347(98)00518-0
10.1016/S0731-7085(03)00652-6
10.1016/S0378-4347(97)88058-9
10.1016/j.pharmthera.2008.02.005
10.1016/j.forsciint.2006.03.018
10.1016/j.jchromb.2004.01.044
10.1016/S0731-7085(02)00002-X
10.1016/S1570-0232(02)00178-2
10.1016/S0731-7085(03)00110-9
10.1093/jn/131.5.1631S
10.1159/000047142
10.1016/S0378-4347(01)00405-4
10.1016/j.chroma.2004.02.074
10.1093/jat/14.3.160
10.1056/NEJMra035092
10.1016/0378-4347(87)80317-1
10.1016/j.microc.2008.09.002
10.1016/S0022-3476(00)98837-1
ContentType Journal Article
Copyright Copyright © 2011 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Copyright_xml – notice: Copyright © 2011 WILEY‐VCH Verlag GmbH & Co. KGaA, Weinheim
– notice: Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
– notice: Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
DBID FBQ
BSCLL
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U5
8FD
L7M
DOI 10.1002/jssc.201100422
DatabaseName AGRIS
Istex
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Solid State and Superconductivity Abstracts
Technology Research Database
Advanced Technologies Database with Aerospace
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
Advanced Technologies Database with Aerospace
Solid State and Superconductivity Abstracts
DatabaseTitleList
CrossRef
MEDLINE
Technology Research Database
Technology Research Database

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: FBQ
  name: AGRIS
  url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN
  sourceTypes: Publisher
DeliveryMethod fulltext_linktorsrc
Discipline Engineering
Chemistry
EISSN 1615-9314
EndPage 3577
ExternalDocumentID 3373116511
10_1002_jssc_201100422
21916010
JSSC201100422
ark_67375_WNG_QXXWL4C1_7
US201400090139
Genre article
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: Mass Spectrometry Core
  funderid: UL1RR025780; 3UL1RR025744‐02S3
– fundername: United States National Institutes of Health
  funderid: P30 DK048520
– fundername: NCRR NIH HHS
  grantid: UL1RR025780
– fundername: NCRR NIH HHS
  grantid: 3UL1RR025744-02S3
– fundername: NIDDK NIH HHS
  grantid: P30 DK048520
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1L6
1OC
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5GY
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AANLZ
AAONW
AASGY
AAXRX
AAZKR
ABCUV
ABDBF
ABHUG
ABIJN
ABJNI
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACIWK
ACPOU
ACXBN
ACXME
ACXQS
ADAWD
ADBBV
ADDAD
ADEOM
ADIZJ
ADKYN
ADMGS
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFFPM
AFGKR
AFPWT
AFVGU
AFZJQ
AGJLS
AI.
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AUFTA
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
EBD
EJD
F00
F01
F04
F5P
FBQ
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
P2P
P2W
P2X
P4D
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RNS
ROL
RWI
RX1
RYL
SUPJJ
TUS
UB1
UPT
VH1
W8V
W99
WBFHL
WBKPD
WIH
WIK
WJL
WOHZO
WRC
WXSBR
WYISQ
XG1
XPP
XV2
YQT
~IA
~KM
~WT
AAHBH
AHBTC
AITYG
BSCLL
HGLYW
OIG
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7U5
8FD
L7M
ID FETCH-LOGICAL-c5012-f94779041cf09a9b637f852d08c766864ee7b726ff445079f0aed04a1f0467313
IEDL.DBID DR2
ISSN 1615-9306
IngestDate Fri Aug 16 06:19:07 EDT 2024
Thu Oct 10 19:43:09 EDT 2024
Fri Aug 23 03:19:05 EDT 2024
Sat Sep 28 08:01:19 EDT 2024
Sat Aug 24 01:09:40 EDT 2024
Wed Oct 30 09:48:51 EDT 2024
Wed Dec 27 19:11:12 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 24
Language English
License Copyright © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5012-f94779041cf09a9b637f852d08c766864ee7b726ff445079f0aed04a1f0467313
Notes http://dx.doi.org/10.1002/jssc.201100422
United States National Institutes of Health - No. P30 DK048520
ArticleID:JSSC201100422
istex:B5206EF59CC7B3932AE33D3E1969237F85646FA7
ark:/67375/WNG-QXXWL4C1-7
Mass Spectrometry Core - No. UL1RR025780; No. 3UL1RR025744-02S3
These authors contributed equally to this work.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
PMID 21916010
PQID 1545103093
PQPubID 105495
PageCount 10
ParticipantIDs proquest_miscellaneous_1022842929
proquest_journals_1545103093
crossref_primary_10_1002_jssc_201100422
pubmed_primary_21916010
wiley_primary_10_1002_jssc_201100422_JSSC201100422
istex_primary_ark_67375_WNG_QXXWL4C1_7
fao_agris_US201400090139
PublicationCentury 2000
PublicationDate December 2011
PublicationDateYYYYMMDD 2011-12-01
PublicationDate_xml – month: 12
  year: 2011
  text: December 2011
PublicationDecade 2010
PublicationPlace Weinheim
PublicationPlace_xml – name: Weinheim
– name: Germany
PublicationTitle Journal of separation science
PublicationTitleAlternate J. Sep. Science
PublicationYear 2011
Publisher WILEY‐VCH Verlag
WILEY-VCH Verlag
Wiley Subscription Services, Inc
Publisher_xml – name: WILEY‐VCH Verlag
– name: WILEY-VCH Verlag
– name: Wiley Subscription Services, Inc
References Clavijo, C. F., Hoffman, K. L., Thomas, J. J., Carvalho, B., Chu, L. F., Drover, D. R., Hammer, G. B., Christians, U., Galinkin, J. L., Anal. Bioanal. Chem. 2011, 400, 715-728.
Esplin, M. S., Obstet. Gynecol. Surv. 2006, 61, 800-806.
Portier, E. J. G., de Block, K., Butter, J. J., Van Boxtel, C. J., J. Chromatogr. B 1999, 723, 313-318.
Palleschi, L., Lucentini, L., Ferretti, E., Anastasi, F., Amoroso, M., Draisci, G., J. Pharm. Biomed. Anal. 2003, 32, 329-336.
Kearns, G. L., Abdel-Rahman, S. M., Alander, S. W., Blowey, D. L., Leeder, J. S., Kauffman, R. E., N. Engl. J. Med. 2003, 349, 1157-1167.
Labroo, R. B., Paine, M. F., Thummel, K. E., Kharasch, E. D., Drug. Metab. Dispos. 1997, 25, 1072-1080.
Yuansheng, L., Yutian, W., Jing, Z., Zhenxing, Z., Zhanxi, Q., Shen, G., Qinghong, K., Xinhua, W., Microchem. J. 1996, 53, 130-136.
Hakkola, J., Raunio, H., Purkunen, R., Saarikoski, S., Vahakangas, K., Pelkonen, O., Edwards, R. J., Boobis, A. R., Pasanen, M., Biol. Neonate 2001, 80, 193-201.
Van Nimmen, N. F., Poels, K. L., Veulemans, H. A., J. Chromatogr. B 2004, 804, 375-387.
Hines, R. N., Pharmacol. Ther. 2008, 118, 250-267.
Naidong, W., Bu, H., Chen, Y., Shou, W. Z., Jiang, X., Halls, T. D. J., J. Pharm. Biomed. Anal. 2002, 28, 1115-1126.
Miller, R. S., Peterson, G. M., Abbott, F., Maddocks, I., Parker, D., McLean, S., Br. J. Clin. Pharmacol. 1995, 40, 553-556.
Van Nimmen, N. F., Veulemans, H. A., J. Chromatogr. A 2004, 1035, 249-259.
Ruangyuttikarn, W., Law, M. Y., Rollins, D. E., Moody, D. E., J. Anal. Toxicol. 1990, 14, 160-164.
Mei, J. V., Alexander, J. R., Adam, B. W., Hannon, W. H., J. Nutr. 2001, 131, 1631S-1636S.
Koch, D. E., Isaza, R., Carpenter, J. W., Hunter, R. P., J. Pharm. Biomed. Anal. 2004, 34, 577-584.
Dotsikas, Y., Loukas, Y. L., Anal. Chim. Acta 2004, 509, 103-109.
Müller, C., Schafer, P., Stortzel, M., Vogt, S., Weinmann, W., J. Chromatogr. B Analyt. Technol. Biomed. Sci. 2002, 773, 47-52.
Fryirsa, B., Woodhouse, A., Huang, J. L., Dawson, M., Mather, L. E., J. Chromatogr. B 1997, 688, 79-85.
Saarenmaa, E., Neuvonen, P. J., Fellman, V., J. Pediatr. 2000, 136, 767-770.
Huynh, N. H., Ttyrefors, N., Ekman, L., Johansson, M., J. Pharm. Biomed. Anal. 2005, 37, 1095-1100.
Bjorksten, A. R., Chan, C., Crankshaw, D. P., J. Chromatogr. B 2002 775, 97-101.
Abdel-Rehim, M., Bielenstein, M., Askemark, Y., Anal. Chim. Acta 2003, 492, 253-260.
Kumar, K., Morgan, D. J., Crankshaw, D. P., J. Chromatogr. 1987, 419, 464-468.
Taddio, A., Clin. Perinatol. 2002, 29, 493-509.
Wang, C., Li, E., Xu, G., Wang, H., Gong, Y., Li, P., Liu, H., He, Y., Microchem. J. 2009, 91, 149-152.
Bagheri, H., Es-haghi, A., Khalilian, F., Rouini, M., J. Pharm. Biomed. Anal. 2007, 43, 1763-1768.
Choia, H. S., Shinb, H., Khanga, G., Rheea, J. M., Leec, H. B., J. Chromatogr. B 2001, 765, 63-69.
McDonald, J., Gall, R., Wiedenbach, P., Bass, V. D., Deleon, B., Brochus, C., Stobert, D., Wei, S., Prange, A., Yang, J. M., Tai, C. L., Weckman, T. J., Woods, W. E., Tai, H. H., Blake, J. W., Tobin, T., Res. Commun. Chem. Pathol. Pharmacol. 1987, 57, 389-407.
Ebrahimzadeh, H., Yamini, Y., Gholizade, A., Sedighi, A., Kasraee, S., Anal. Chim. Acta 2008, 626, 193-199.
Dotsikas, Y., Loukas, Y. L., Siafaka, I., Anal. Chim. Acta 2002, 459, 177-185.
Coopman, V., Cordonier, J., Pien, K., van Varenbergh, D., Forensic Sci. Int. 2007, 169, 223-227.
2007; 169
1987; 57
1990; 14
2000; 136
2002; 773
1997; 25
2003; 492
2008; 626
2002; 459
2002; 775
2004
1999; 723
2004; 804
2004; 509
2003; 32
1996; 53
2001; 765
2001; 80
2002; 28
1995; 40
2011; 400
1997; 688
2003; 349
2006; 61
2002; 29
2001; 131
2001
2009; 91
2004; 34
2008; 118
1987; 419
2005; 37
2004; 1035
2007; 43
e_1_2_7_5_2
e_1_2_7_4_2
e_1_2_7_3_2
e_1_2_7_2_2
e_1_2_7_9_2
Miller R. S. (e_1_2_7_33_2) 1995; 40
e_1_2_7_7_2
e_1_2_7_6_2
e_1_2_7_19_2
e_1_2_7_18_2
e_1_2_7_17_2
e_1_2_7_16_2
e_1_2_7_15_2
e_1_2_7_14_2
e_1_2_7_13_2
e_1_2_7_12_2
e_1_2_7_11_2
e_1_2_7_10_2
e_1_2_7_26_2
e_1_2_7_27_2
e_1_2_7_28_2
Labroo R. B. (e_1_2_7_8_2) 1997; 25
e_1_2_7_25_2
e_1_2_7_24_2
e_1_2_7_30_2
e_1_2_7_23_2
e_1_2_7_31_2
e_1_2_7_22_2
e_1_2_7_32_2
e_1_2_7_21_2
e_1_2_7_20_2
e_1_2_7_34_2
e_1_2_7_35_2
McDonald J. (e_1_2_7_29_2) 1987; 57
e_1_2_7_36_2
References_xml – volume: 775
  start-page: 97
  year: 2002
  end-page: 101
  publication-title: J. Chromatogr. B
– volume: 509
  start-page: 103
  year: 2004
  end-page: 109
  publication-title: Anal. Chim. Acta
– volume: 53
  start-page: 130
  year: 1996
  end-page: 136
  publication-title: Microchem. J.
– volume: 459
  start-page: 177
  year: 2002
  end-page: 185
  publication-title: Anal. Chim. Acta
– volume: 492
  start-page: 253
  year: 2003
  end-page: 260
  publication-title: Anal. Chim. Acta
– volume: 626
  start-page: 193
  year: 2008
  end-page: 199
  publication-title: Anal. Chim. Acta
– volume: 688
  start-page: 79
  year: 1997
  end-page: 85
  publication-title: J. Chromatogr. B
– volume: 419
  start-page: 464
  year: 1987
  end-page: 468
  publication-title: J. Chromatogr.
– volume: 804
  start-page: 375
  year: 2004
  end-page: 387
  publication-title: J. Chromatogr. B
– year: 2001
– volume: 29
  start-page: 493
  year: 2002
  end-page: 509
  publication-title: Clin. Perinatol.
– volume: 349
  start-page: 1157
  year: 2003
  end-page: 1167
  publication-title: N. Engl. J. Med.
– volume: 136
  start-page: 767
  year: 2000
  end-page: 770
  publication-title: J. Pediatr.
– volume: 43
  start-page: 1763
  year: 2007
  end-page: 1768
  publication-title: J. Pharm. Biomed. Anal.
– volume: 61
  start-page: 800
  year: 2006
  end-page: 806
  publication-title: Obstet. Gynecol. Surv.
– volume: 400
  start-page: 715
  year: 2011
  end-page: 728
  publication-title: Anal. Bioanal. Chem.
– volume: 118
  start-page: 250
  year: 2008
  end-page: 267
  publication-title: Pharmacol. Ther.
– volume: 37
  start-page: 1095
  year: 2005
  end-page: 1100
  publication-title: J. Pharm. Biomed. Anal.
– volume: 1035
  start-page: 249
  year: 2004
  end-page: 259
  publication-title: J. Chromatogr. A
– volume: 765
  start-page: 63
  year: 2001
  end-page: 69
  publication-title: J. Chromatogr. B
– volume: 131
  start-page: 1631S
  year: 2001
  end-page: 1636S
  publication-title: J. Nutr.
– volume: 723
  start-page: 313
  year: 1999
  end-page: 318
  publication-title: J. Chromatogr. B
– volume: 40
  start-page: 553
  year: 1995
  end-page: 556
  publication-title: Br. J. Clin. Pharmacol.
– volume: 25
  start-page: 1072
  year: 1997
  end-page: 1080
  publication-title: Drug. Metab. Dispos.
– volume: 57
  start-page: 389
  year: 1987
  end-page: 407
  publication-title: Res. Commun. Chem. Pathol. Pharmacol.
– year: 2004
– volume: 773
  start-page: 47
  year: 2002
  end-page: 52
  publication-title: J. Chromatogr. B Analyt. Technol. Biomed. Sci.
– volume: 169
  start-page: 223
  year: 2007
  end-page: 227
  publication-title: Forensic Sci. Int.
– volume: 32
  start-page: 329
  year: 2003
  end-page: 336
  publication-title: J. Pharm. Biomed. Anal.
– volume: 14
  start-page: 160
  year: 1990
  end-page: 164
  publication-title: J. Anal. Toxicol.
– volume: 28
  start-page: 1115
  year: 2002
  end-page: 1126
  publication-title: J. Pharm. Biomed. Anal.
– volume: 80
  start-page: 193
  year: 2001
  end-page: 201
  publication-title: Biol. Neonate
– volume: 34
  start-page: 577
  year: 2004
  end-page: 584
  publication-title: J. Pharm. Biomed. Anal.
– volume: 91
  start-page: 149
  year: 2009
  end-page: 152
  publication-title: Microchem. J.
– ident: e_1_2_7_15_2
  doi: 10.1016/j.jpba.2004.09.024
– ident: e_1_2_7_32_2
  doi: 10.1016/S1570-0232(02)00142-3
– volume: 57
  start-page: 389
  year: 1987
  ident: e_1_2_7_29_2
  publication-title: Res. Commun. Chem. Pathol. Pharmacol.
  contributor:
    fullname: McDonald J.
– ident: e_1_2_7_27_2
  doi: 10.1016/j.aca.2003.12.007
– ident: e_1_2_7_20_2
  doi: 10.1006/mchj.1996.0017
– ident: e_1_2_7_36_2
  doi: 10.1007/s00216-011-4775-z
– ident: e_1_2_7_2_2
  doi: 10.1097/01.ogx.0000248747.52343.5f
– ident: e_1_2_7_30_2
– ident: e_1_2_7_11_2
  doi: 10.1016/S0003-2670(03)00574-9
– ident: e_1_2_7_16_2
  doi: 10.1016/j.aca.2008.07.047
– ident: e_1_2_7_4_2
  doi: 10.1016/S0095-5108(02)00017-9
– ident: e_1_2_7_28_2
  doi: 10.1016/S0003-2670(02)00133-2
– ident: e_1_2_7_22_2
  doi: 10.1016/j.jpba.2006.12.016
– ident: e_1_2_7_10_2
  doi: 10.1016/S0378-4347(98)00518-0
– ident: e_1_2_7_14_2
  doi: 10.1016/S0731-7085(03)00652-6
– ident: e_1_2_7_18_2
  doi: 10.1016/S0378-4347(97)88058-9
– ident: e_1_2_7_5_2
  doi: 10.1016/j.pharmthera.2008.02.005
– ident: e_1_2_7_17_2
  doi: 10.1016/j.forsciint.2006.03.018
– ident: e_1_2_7_19_2
  doi: 10.1016/j.jchromb.2004.01.044
– ident: e_1_2_7_31_2
– ident: e_1_2_7_12_2
  doi: 10.1016/S0731-7085(02)00002-X
– ident: e_1_2_7_25_2
  doi: 10.1016/S1570-0232(02)00178-2
– ident: e_1_2_7_13_2
  doi: 10.1016/S0731-7085(03)00110-9
– ident: e_1_2_7_35_2
  doi: 10.1093/jn/131.5.1631S
– ident: e_1_2_7_6_2
  doi: 10.1159/000047142
– ident: e_1_2_7_3_2
– ident: e_1_2_7_24_2
  doi: 10.1016/S0378-4347(01)00405-4
– ident: e_1_2_7_21_2
  doi: 10.1016/j.chroma.2004.02.074
– ident: e_1_2_7_26_2
  doi: 10.1093/jat/14.3.160
– volume: 40
  start-page: 553
  year: 1995
  ident: e_1_2_7_33_2
  publication-title: Br. J. Clin. Pharmacol.
  contributor:
    fullname: Miller R. S.
– ident: e_1_2_7_7_2
  doi: 10.1056/NEJMra035092
– volume: 25
  start-page: 1072
  year: 1997
  ident: e_1_2_7_8_2
  publication-title: Drug. Metab. Dispos.
  contributor:
    fullname: Labroo R. B.
– ident: e_1_2_7_9_2
  doi: 10.1016/0378-4347(87)80317-1
– ident: e_1_2_7_23_2
  doi: 10.1016/j.microc.2008.09.002
– ident: e_1_2_7_34_2
  doi: 10.1016/S0022-3476(00)98837-1
SSID ssj0017890
Score 2.220823
Snippet Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the most...
Abstract Preterm and term neonates often require surgical procedures and analgesia. However, our knowledge about neonatal pharmacokinetics of fentanyl, the...
SourceID proquest
crossref
pubmed
wiley
istex
fao
SourceType Aggregation Database
Index Database
Publisher
StartPage 3568
SubjectTerms Analgesia
Assaying
Blood
Blood Volume
Child
Children
Chromatography, High Pressure Liquid
DBS
Despropionyl fentanyl
Dried blood spots
Fentanyl
Fentanyl - analogs & derivatives
Fentanyl - blood
Fentanyl - metabolism
Human plasma
Humans
ions
Matrices
Metabolites
monitoring
neonates
Norfentanyl
pharmacokinetics
Sensitivity and Specificity
surgery
Tandem Mass Spectrometry
Title low blood volume LC‐MS/MS assay for the quantification of fentanyl and its major metabolites norfentanyl and despropionyl fentanyl in children
URI https://api.istex.fr/ark:/67375/WNG-QXXWL4C1-7/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjssc.201100422
https://www.ncbi.nlm.nih.gov/pubmed/21916010
https://www.proquest.com/docview/1545103093
https://search.proquest.com/docview/1022842929
Volume 34
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwELagF-BAoTyaUpCREJzSjRPndawCpaq6lSCsujfLcWy0fSRlkxWUEz8B8RP5Jcw4m7SLkJDgGMVO5PF45ht75jMhL3SiNcSyhRt5JnDBQ0s3VUnkplEpFTOpzxTWO4-Pov0JP5iG02tV_B0_xLDhhivD2mtc4LJoRlekoSdNoywFp6WxAiPMghhzul6_H_ijGFZ5YsQFbttNARz3rI2eP1rtvuKVbhpZA1ZFMX_5E_BcxbHWEe2tE9kPocs_Od1ZtMWO-vobu-P_jPEeubtEqXS3U6v75IauNsitrL8cboPcucZj-ID82KVn9Wdqk-BpZ-_oYfbz2_dxPhrnFPC5vKSAjimgTfppIbsEJasTtDbUYP56dXlGZVXSWdvQc3kCjc91CxqKNdINrer5SqtSNyCAixnm1V_1n1W0L05_SCZ7bz5k--7ysgdXheAkXZNypD7kTBkvlWkRBbFJQr_0EhVHURJxreMi9iNjOAcMmxpP6tLjkhmI8OOABY_IWlVXepPQmGmlU11EHtccDHqilAZYCpGqDoswTBzyqp9scdFxeoiOvdkXKHExSNwhm6ALQn4EgysmuY_hKIBShM0OeWkVZPiCnJ9iklwciuOjt-LddHp8yDMmYods9xoklvahEQhcmT2Fdsjz4TXMIR7XyErXC2iD1ER4mxj863GnecPPwM8wDKUd4lv9-cs4xEGeZ8PT1r90ekJu2-10m8mzTdba-UI_BTzWFs_smvsFapgq1Q
link.rule.ids 315,783,787,1378,27938,27939,46308,46732
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RcigcCpRHAwWMhOCUbpLN81gFylJ2V4J01b1ZjtdG20fSbnYF5cRPQPxEfgkzziZlERISHKPYiTwez3xjz3wGeK5ipTCWze3Q0V0bPbSwExmHdhJOhHR14rmS6p0Hw7A38g_GQZNNSLUwNT9Eu-FGK8PYa1rgtCHduWINPa4qaTg4DY_VGlzHNd-lSwxefWgZpFyq86SYCx23nSA8bngbHa-z2n_FL61pUSJaJUF__hP0XEWyxhXt34K8GUSdgXKyu5jnu_LLb_yO_zXK27C5BKpsr9asO3BNFVuwkTb3w23BzV-oDO_C9z12Wn5iJg-e1SaP9dMfX78Nss4gYwjRxSVDgMwQcLKLhahzlIxasFIzTSnsxeUpE8WETecVOxPH2PhMzVFJqUy6YkU5W2k1URVK4HxKqfVX_acFa-rT78Fo__Vh2rOX9z3YMkA_aevEJ_ZD35XaSUSSh91Ix4E3cWIZhWEc-kpFeeSFWvs-wthEO0JNHF-42qGpd7v3Yb0oC7UNLHKVVInKQ8dXPtr0WEqFyBSDVRXkQRBb8LKZbX5e03rwmsDZ4yRx3krcgm1UBi4-os3lo8yjiBRxKSFnC14YDWm_IGYnlCcXBfxo-Ia_H4-P-n7q8siCnUaF-NJEVJywq2sOoi141r7GOaQTG1GocoFtiJ2ILhTDfz2oVa_9Gboal6JpCzyjQH8ZBz_IsrR9evgvnZ7CRu9w0Of9t8N3j-CG2V03iT07sD6fLdRjhGfz_IlZgD8BB9su7w
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1fb9MwED-xIQF74M-ALTDASAiesiap4ySPU0cZo62AUq1vluPYqPuTlKYVjCc-AuIj8kk4O022IiQkeIxiJ_L5fPc7--5ngGcqVgpj2dRlnm676KGFm8iYuQnLhPR1EvjS1Dv3B-xgRA_H4fhSFX_FD9FsuJmVYe21WeDTTLcuSEOPy1JaCk5LY7UGVylreyapa_99QyDlmzJPE3Kh33YTRMc1baMXtFb7r7ilNS0KBKtGzl_-hDxXgaz1RN1bIOoxVAkoJ7uLeborv_5G7_g_g7wNN5cwlexVenUHrqh8E6536tvhNmHjEpHhXfixR06Lz8RmwZPK4JFe5-e37_1hqz8kCNDFOUF4TBBukk8LUWUoWaUghSbaJLDn56dE5BmZzEtyJo6x8Zmao4qaIumS5MVspVWmShTAdGIS6y_6T3JSV6ffg1H35YfOgbu87cGVIXpJVyfUcB9SX2ovEUnK2pGOwyDzYhkxFjOqVJRGAdOaUgSxifaEyjwqfI0hftT22_dhPS9ytQ0k8pVUiUqZRxVFix5LqRCXYqiqwjQMYwde1JPNpxWpB6_omwNuJM4biTuwjbrAxUe0uHw0DEw8iqjU4GYHnlsFab4gZicmSy4K-dHgFX83Hh_1aMfnkQM7tQbxpYEouUGuvj2GduBp8xrn0JzXiFwVC2xjuInMdWL4r61K85qfoaPxTSztQGD15y_j4IfDYad5evAvnZ7Atbf7Xd57PXjzEG7YrXWb1bMD6_PZQj1CbDZPH9vl9wtLmC2e
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+low+blood+volume+LC-MS%2FMS+assay+for+the+quantification+of+fentanyl+and+its+major+metabolites+norfentanyl+and+despropionyl+fentanyl+in+children&rft.jtitle=Journal+of+separation+science&rft.au=Clavijo%2C+Claudia+F.&rft.au=Thomas%2C+James+Joseph&rft.au=Cromie%2C+Meghan&rft.au=Schniedewind%2C+Bj%C3%B6rn&rft.date=2011-12-01&rft.pub=WILEY-VCH+Verlag&rft.issn=1615-9306&rft.eissn=1615-9314&rft.volume=34&rft.issue=24&rft.spage=3568&rft.epage=3577&rft_id=info:doi/10.1002%2Fjssc.201100422&rft.externalDBID=n%2Fa&rft.externalDocID=ark_67375_WNG_QXXWL4C1_7
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1615-9306&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1615-9306&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1615-9306&client=summon